ImmunoMolecular Therapeutics' Unattributed Round

ImmunoMolecular Therapeutics raised a round of funding on June 30, 2015.

ImmunoMolecular Therapeutics is a private clinical stage biotech company developing a revolutionary therapeutic approach for the treatment of Type I Diabetes. The company was founded by world class r…

Articles about ImmunoMolecular Therapeutics' Unattributed Round: